331 results
Page 5 of 17
424B5
9fuhbsfb tmpjvtsnr5
12 Nov 20
Prospectus supplement for primary offering
4:21pm
424B3
8lq40v q15
9 Nov 20
Prospectus supplement
8:20am
8-K
EX-99.1
jczoxo9ob57nc5syl
5 Nov 20
Bristol Myers Squibb Reports Third Quarter 2020 Financial Results
8:10am
SC TO-T
EX-99
098yg51uy7ut4m lp
19 Oct 20
Third party tender offer statement
6:03am
SC TO-T
EX-99
bjjc24yb alht41x
19 Oct 20
Third party tender offer statement
6:03am
SC TO-C
EX-99.2
mn7g3m3xyfd88 8so638
5 Oct 20
Information about tender offer
5:13pm
SC TO-C
EX-99.1
lr5rff7bq1wt52a
5 Oct 20
Information about tender offer
5:13pm
SC TO-C
EX-99.3
vyrc4y
5 Oct 20
Information about tender offer
5:13pm
8-K
EX-99.1
o2bug fdw9oaljur9zaa
5 Oct 20
Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash
4:05pm
8-K
EX-99.1
qt4o 11nm7qu6xh6
6 Aug 20
Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
7:57am
8-K
EX-99.1
05pengm6gzt73xjp
16 Jul 20
Bristol Myers Squibb Announces Expiration and Final Results of Registered Exchange Offers
8:30am
8-K
EX-99.1
ncnq7se17 tf7
16 Jun 20
Bristol Myers Squibb Announces Commencement of Registered Exchange Offers
8:39am
424B3
4hfo5sfd170 m9r5v28
16 Jun 20
Prospectus supplement
8:01am
8-K
EX-99.1
alaflgdjiqke71ky24k
7 May 20
Bristol Myers Squibb Reports Strong First Quarter 2020 Financial Results
8:08am
DEFA14A
nll3ulrsb zqgxel4r
23 Apr 20
Additional proxy soliciting materials
8:59am
8-K
EX-99.1
uefhi6qle3359rn
14 Apr 20
Bristol Myers Squibb Announces Virtual 2020 Annual Meeting of Shareholders
4:36pm